MedWatch

Sitemap

CHMP recommends nine new drugs, rejects one CEO at WSA: No clarity on EQT exit plans yet EU Commission ends Danish HERA dreams – but could provide new opportunities for the pharmaceutical industry Oticon: Covid-19 led to debates about product launches WS Audiology still chewing over listing of online hearing company New EU health authority to respond rapidly to future health threats Lundbeck Foundation buys stake in asset manager Demant CEO: It will take a long time to meet pent-up demand Sonova enters strategic alliance with French biotech company to treat hearing loss Snipr Biome and US cancer hospital target gut microbes in attempt to eradicate immune therapy side effects Jefferies downgrades Genmab recommendation due to lack of short-term catalysts New data a boost for Johnson & Johnson and Bavarian Nordic's Ebola vaccine IO Biotech begins phase III trial with partner MSD WS Audiology makes headway in green conversion of Singapore headquarters Novo Nordisk starts crucial trial of obesity tablet Novo Nordisk Foundation grants USD 46m to new genomics research center in Boston Sonova says surge of Delta cases in US hasn't affected hearing aid market Ambu changes stance, mandates vaccines for US workers Leo Pharma will not use acquisition option after candidate disappoints in phase III trial Italian hearing aid retailer expects first OTC products in 2022 EU to present plans for new emergency health authority on Thursday Olympus survives malware attack without data loss Y-mabs receives priority review status for cancer drug in China Investment bank raises guidance for Novo Nordisk after "impressive" Wegovy launch Galecto begins third phase II trial Italian hearing aid retailer disappoints with growth prognosis Snipr Biome to collaborate with US cancer hospital Novo Holdings sets sights on more acquisitions in hot bioindustry sector ABG hires equity analyst to cover hearing health and pharmaceutical companies Lundbeck CEO joins board of directors at Syros Pharmaceuticals No needles in sight as Novo succeeds with new capsule technology Denmark sells 500,000 surplus vaccines to New Zealand Top news from MedWatch this week Eli Lilly to raise millions for green initiatives Sanofi opines on Danish government's Bavarian contract: Single supplier would be a mistake Swedish diabetes company raises USD 17.5m for phase III trial Former Lundbeck CEO: Voicing public opinions isn't always prudent Novo Nordisk's new VP of digital health to focus on internal and external innovation Eli Lilly and Boehringer Ingelheim's Jardiance against heart failure achieves breakthrough designation from FDA Analyst thinks RSV vaccine market could reach over USD 10bn Sanofi's big dermatology hope fails in phase III Coloplast axed traditional budgeting process: "It wasn't promoting growth" Lundbeck to measure brain with microscopic camera in new partnership Bavarian increases capital of USD 8.9m from selling shares Horizon begins phase four clinical trial of Genmab drug Investors worry about Lundbeck's future, analysts remain optimistic Ascendis ready with clinical trial of another cancer drug Coloplast opens new factory in Costa Rica Ambu leadership under scrutiny for communication style EMA begins assessment of Pfizer booster application Danish government wants to spend USD 160m on permanent research and development tax deduction Fujifilm's factory in Denmark generates USD 430m revenue Biogen takes second royalties victory in blow for Forward Pharma Danish government cancels vaccine production tender WS Audiology brings in VP of accounting and head of communications Demant on the hunt for employees: "Even high-level people are on the phone" Despite recent successes, Bavarian remains second-most shorted stock on Nasdaq Copenhagen Astrazeneca and EU settle missing vaccines case Top news from MedWatch this week Analysts upgrade share price targets for Bavarian after run of good news Zealand Pharma Chief Medical Officer sells shares worth USD 650,000 Bank skeptical about Novo Nordisk share price – requires USD 40bn a year in obesity drug sales Pfizer begins phase III trial for vaccine against RSV Sobi co-founder thinks acquisition is likely after USD 8bn bid Investment bank: Bavarian Nordic's RSV data reduces risk associated with important asset Lundbeck starts new study of tablet version of drug Pentax rejects Ambu's claims of head start Most US employers say vaccine mandates are possible by end of year Ascendis Pharma aims for USD 400m from share issue Bavarian Nordic: RSV efforts could be "key to the promised land" Bavarian Nordic reports promising results for RSV vaccine in phase II trial No room for more mistakes at Lundbeck Orphazyme may face class action suit from US investors Leo Pharma swims against US tide by allowing unvaccinated staff Orphazyme expects to lay off 100 employees this year Pfizer goes head to head with Sanofi's multi-blockbuster with new study data UK denies approval for Genmab's Darzalex combo Sonion chair blames pandemic for CEO exit Sonion changes CEO for second time in two years Sanofi gets positive results for eczema treatment – this time in young children New study provides good results for Eli Lilly and Boehringer Top news from MedWatch this week Ascendis ready for new hires after FDA approval New factory takes AGC Danmark to another level within the corporation WS Audiology reports massive growth in Europe compared to pre-pandemic levels Ascendis aiming to become market leader Lundbeck introduces vaccine requirement for US staff Bavarian Nordic: State gains from vaccine support capped by contract Novo Nordisk after US delivery issues: New obesity drug launch set for H2 next year FDA approves Ascendis' weekly growth hormone WS Audiology: Quarterly reports will improve transparency Vertex spends billions on CRISPR technology in search of diabetes cure WS Audiology continues to prioritize Signia on Veterans Affairs channel WS Audiology revenue and operating result increase significantly Bavarian Nordic releases more specific guidance - downgrades expectations Medtronic reports good start to fiscal year Danish Medicines Council rejects Johnson & Johnson's psoriasis medicine: "Worse than existing standard treatment" Delayed Danish state Covid vaccine to be trialled on humans in 2022 AGC Biologics breaks ground on USD 190m Danish factory Bavarian Nordic CEO sees massive sales potential for Covid-19 vaccine after securing state aid EU approves Danish plan to put EUR 108m behind Bavarian Nordic's Covid-19 vaccine Coloplast CEO struggling to find good acquisition candidate Coloplast sets climate goals for executive bonus program Bavarian Nordic initiates phase II trial for Covid-19 vaccine Xellia's delayed factory now up and running Lundbeck CEO on most controversial drug approval in recent memory: Will bring new innovation GN Hearing eyes opportunities for new product in coming US sales channel Coloplast drops prior skepticism, agrees to divulge national tax information Novo Nordisk expects to cover demand for obesity drug in 2022 New GN device to open giant market for mild hearing loss Unvaccinated staff not welcome at Novo Nordisk's US HQ Lundbeck partner soon to seek approval for new Abilify Maintena version Eli Lilly's diabetes drug approved to treat heart failure Coloplast seeks more US catheter acquisitions: "We want increased coverage" GN Hearing disappoints despite high Q2 growth – maintains annual guidance Covid-stricken US still causing Lundbeck problems Coloplast notes advance for all four units, adjusts annual guidance New trial shows top-selling Lundbeck drug not beating placebo for borderline Eli Lilly in big reshuffle: Sets up new units for neuroscience and immunology Capacity problems accelerated Ambu's construction of world's largest endoscope plant Lundbeck upgrades annual earnings guidance, cuts revenue outlook Ambu launches new duodenoscope in four weeks Covid-19 pins geographic needles in Ambu's core business – CEO hopes for stabilization ahead Lundbeck report could trigger upgrade despite headwind Ambu joins green climate initiative Analyst forecasts YoY quarterly growth for Coloplast following virus year Ambu's Q3 ended better than expected Ambu overture: Weakened demand and bottlenecks burden quarter Eli Lilly scores positive phase III results with new eczema treatment Novo Nordisk plugs hemorrhage with lucrative Biopharm unit restored to growth Genmab considers vaccine requirement for staff Zealand Pharma CEO: Zegalogue launch continues as planned Bose expands to whole US with new direct-to-consumer hearing aid Biogen's Alzheimer's drug denied support by Veteran Affairs ALK acquires drug against swimmer's ear from now former US partner Demant benefits from French reform more than projected Demant CEO: Ketchup effect could lead to above-average growth in 2022 and 2023 Boehringer Ingelheim and Gubra send obesity drug candidate to clinical trial Genmab: Janssen dispute cost DKK 146m in H1 Genmab's successful CEO dismisses retirement plans Demant closes Q2 ahead of guidance, upgrades both revenue and earnings Postponed clinical trials affect ALK finances – central phase III trials have been delayed FDA approves single-use bronchoscope from Boston Scientific Analysts predict possible 2021 guidance upgrade from Demant GN Hearing and Demant lose market shares in VA ALK increases sales in Q2, but operating result decreases Analyst predicts progress in Demant's H1 Lundbeck breathes life into stranded molecule to treat new diseases Jefferies fears renewed pressure on Novo Nordisk's growth ALK upgrades guidance following convincing sales and savings Bavarian Nordic CEO notes progress in vaccine funding talks with Danish government Bavarian Nordic: Covid-19 vaccine beats Pfizer's on several parameters Astellas shakes structure of R&D division Lundbeck closes RNA deal worth USD 109m with US biotech firm Major US bank shoots way above Novo Nordisk's own goals: New obesity drug will sell for almost USD 3.5bn in 2025. US authority increases subsidies for single-use duodenoscopes – which benefits both Ambu and Boston Scientific Top news from MedWatch this week Novo Nordisk plans to test cholesterol-lowering oral solution in phase II trial Orphazyme postpones financial report ALK nominates former Sanofi executive for board membership Olympus upgrades guidance following better-than-expected report Novo Nordisk's new obesity drug hits 8,000-prescription mark in few weeks: Comparing with Saxenda, it took around four years Bank analyst on Novo Nordisk report: Impressive quarter, to say the least Novo Nordisk upgrades guidance for the rest of the year Denmark has shipped half a million vaccines to Ukraine Media: Pfizer's covid-19 vaccine will soon get full approval in the US Lead-up to Novo Nordisk report: Growth-heavy quarter with GLP-1 focus ahead EU approves upscaling of Moderna vaccine in US production facilities Eli Lilly specifies guidance for this year's revenue Anders Dyhr Toft waves goodbye to Novo Nordisk after 18 years to become the CMO of Synact: "It's going to be more DIY-based" Pfizer launches phase III trial with RSV candidate in September Danish scientists raise alarm after discovering link between Bayer drug and brain cancer Pfizer and Moderna raise prices for coronavirus vaccines Novo Nordisk's Wegovy sells like hot cakes in the US – increases production ALK closes largest deal in 10 years – gets DKK 90m for partnership in China on adrenaline autoinjector Danish State Serum Institute launches world's largest investigation of late effects from covid-19 Takeda surpasses analyst forecasts in Q1 Amplifon doubles Q2 sales and upgrades 2021 guidance Biomarin prepares for European approval of Ascendis competitor Smith & Nephew revenue better than expected, but operating result disappoints FDA makes historic ruling on biosimilar insulin Sanofi upgrades 2021 guidance after sales of Dupixent and diabetes products increase Investors: Novo Nordisk's obesity efforts will lead to growth Pfizer upgrades guidance for sales of covid-19 vaccine Pharma industry is discretely working against a global tax agreement GN Hearing top exec stops after 17 years – replacement found within own ranks Astrazeneca shot shows no increased clot risk after two doses Boston Scientific reports significant growth in endoscopy business – grows 54 percent Biontech plans to examine mRNA technology for malaria vaccines Nordic Capital in talks to buy healthtech firm Inovalon Pfizer and Biontech expand study of vaccines for children FDA gives Saniona candidate priority status Allarity keeps streamlining pipeline – sells cancer drug for USD 18m Sweden phases out AstraZeneca's covid-19 vaccine CHMP recommends Moderna covid-19 vaccine for approval in 12-17-year-olds CHMP recommends two new drugs for approval and rejects one Top news from MedWatch this week Roche's hemophilia treatment well on the way to triple blockbuster status Lundbeck to trial migraine drug in young people Over half of all adults in the EU are now fully vaccinated against covid-19 Biogen upgrades financial guidance after exceeding expectations in Q2 EMA pays respects after sudden death of Research and Innovation leader Össur key market sales normalize during second quarter Hemab raises USD 55m for treatment of rare bleeding disorders Analyst: Genmab may upgrade financial guidance based on Darzalex sales figures Darzalex sales exceed expectations in second quarter Sclerosis drug developed by Genmab brings in USD 66m to Novartis during Q2 Leo Pharma brings in old friends and new blood for eczema treatment launch EMA starts continual assessment of Sanofi's corona vaccine Denmark's largest companies report huge expansions to legal departments Novo Nordisk bets on RNA in several business areas Saniona borrows USD 10m for clinical studies MC2 Therapeutics launches psoriasis cream in US Pfizer executive: "It is hugely important that the world prepares itself for potential future pandemics" Pharmacosmos predicts record financial year after launches in US and China Eli Lilly and Incyte's eczema treatment delayed at FDA – again Top news from MedWatch this week Sales of Novo Nordisk's Victoza drop in US With launches on the way in the US and EU, MC2 turns attention to the rest of its pipeline GN Hearing shrinks again and Denmant's growth proves short-lived on VA channel Eli Lilly allies itself with Alzheimer's institute in phase III dementia drug trials Covid vaccine makers target bottlenecks to speed up production Pharmacosmos' revenue grows by USD 16m despite corona challenges Genmab surpasses 1,000 employees Billionaire Moderna founder and world's most cited engineer sees "pretty unlimited" potential in mRNA Eli Lilly acquires biotech firm in new insulin venture Dane overcomes Tokyo culture shock to run Lundbeck's most successful launch Novo Nordisk, Sanofi and Eli Lilly face court in US over insulin prices Researchers trick malaria parasites with new vaccine Hearing industry challenger applauds Biden's price battle Experts: The world needs more than just mRNA vaccines Janssen gets FDA approval for new Darzalex combination Amplifon buys Bay Audio for DKK 2.6bn US sees global tax agreement as beneficial for all Novo Nordisk buys treatment candidate for rare disease for up to USD 1.2bn Pharma giants see huge potential in new "super technology" for fighting a wide range of diseases EMA currently sees no need for Covid booster jab Analyst: Biden attack on pharmaceutical industry seems symbolic Top news from MedWatch this week New Biden order criticizing hearing aid expense causes falling share prices Biden starts new offensive to bring down medicine prices FDA changes prescribing information for new Alzheimer's drug WSA buys US retail chain Brazilian success: SynAct Pharma scores positive results with therapy for covid-19 Sanofi pays up to USD 1bn for new multiple myeloma therapy Sales of Biohaven's migraine tablet exceed expectations Novo Nordisk veteran takes up CMO position at Danish-Swedish biotech company Almirall partner MC2 on the verge of EU victory after ten years of hard work Novo Holdings invests huge sums in the US Ascendis moves forward with phase III drug Novo Nordisk Pharmatech closes distribution agreement for Russia and CIS countries Amplifon expands Chinese presence in new joint venture Boehringer and Eli Lilly meet primary endpoints in heart failure treatment studies Almirall opens submissions for new dermatology partnerships MC2 and Almirall clear crucial obstacle to psoriasis treatment in Europe Lundbeck hands over former Alzheimer's candidate to privately-owned biotech company Leo Pharma to collaborate with US biotech company BioNTech/Pfizer vaccine is less effective against Delta variant Ambu brings plans for Mexico factory forward Orphazyme investors snatched up profits before FDA failure Bank bemused by Ambu downgrade New Coloplast Senior Vice President: MDR will guide our innovation focus in the future Top news from MedWatch this week 130 countries enter into tax reform agreement Conflicts of interest have kept Lars Rebien Sørensen away from pharmaceutical boards – until now New chairman to prepare Leo Pharma for IPO with new launches and financial discipline Ambu downgrades due to covid-19 and logistical challenges EMA second-in-command retires after 25 years at the organization Leo Pharma appoints former Novo Nordisk CFO as new chairman of the board EQT and owner family divest Fertin Pharma to Philip Morris International for DKK 5.1bn Ferring appoints Lars Rebien Sørensen as new chairman Novo Nordisk closes deal on technology platform Zealand Pharma President of US Operations on first launch: Timing was our most important goal WSA raises ESG ambitions Novo Nordisk sticks to cautious obesity sales goal Novo Nordisk's analog insulin will be sold cheaply in Walmart Eli Lilly welcomes competition for cheap insulin in US AGC Biologics contacted minister over Danish vaccine collaboration before PM announcement Sanofi to establish mRNA vaccine center with 400 employees Two main factors behind Sanofi's dialog with Danish authorities Vifor Pharma gets new CEO Novo Nordisk wants to innovate in new ways to find cures Oticon Medical General Manager after US FDA approval: It's a competitive situation Ambu gets recommendation from FDA, analyst doubts effect Sanofi reveals detailed timeframe for RSV candidate FDA recommends single-use bronchoscopes Orphazyme to get rid of two thirds of employees Top news from MedWatch this week CHMP recommends eight new drugs for approval – one cancer drug rejected ECDC wants to bring forward second jab to tame variant Australian firm acquires Denmark's largest cannabis company Pharmacosmos launches cell therapy market offensive Oticon president satisfied with FDA approval: "A huge milestone" Stallergenes Greer production back to full capacity after years of limited activity Zealand Pharma sends blood sugar drug to US market Lilly gets sought-after FDA designation for Alzheimer's candidate Oticon Medical gets FDA approval for cochlear implant Novo Holdings sees golden opportunity in dialysis company, contributes to USD 245m investment Amgen gets Japanese authorization for migraine drug Y-mabs delayed again in the US US dermatology top boss moves to Danish biotech firm Goldman Sachs reduces share in Orphazyme and drops below 5 percent boundary Leo Pharma receives UK approval for Adtralza Biogen criticized in the US over price of new Alzheimer's drug Janssen gets expanded authorization for Genmab's Darzalex in EU Leo Pharma starts study of eczema tablet for nettle rash EMA continues to review link between myocarditis and coronavirus vaccination Financial analyst: Novo Nordisk's obesity treatment could triple market Novo Nordisk expands collaboration with US app company Roche's digital health venture boosted by pandemic Leo Pharma's new drug for atopic dermatitis receives EU approval Bavarian Nordic CEO frustrated with lack of reply on financial support for vaccine candidate Coloplast sees potential in Russia Series of setbacks have not caused Orphazyme CEO to consider departing FDA approves new Ambu product Orphazyme not seeking fresh capital despite reduced cash position EU and Astrazeneca each declare lawsuit victory Novo Nordisk CEO's pay sets itself apart on especially one point Top news from MedWatch this week Orphazyme CEO silent on potential firings in wake of FDA rejection US OTC hearing aid channel back on Department of Health agenda EMA hesitates over flunking Curevac vaccine despite missed target Top Orphazyme figure on FDA rejection: "It is very disappointing and very unexpected" Orphazyme cuts guidance following FDA setback More disappointment for Orphazyme as FDA rejects Niemann Pick C application Bavarian Nordic: Vaccine production almost came to Denmark Utility Therapeutics prepares FDA application Novo Holdings hot on diagnostics: This is the key to unlocking two of the largest healthcare issues Olympus on former Ambu CEO's advisory role: "He will be a big asset" Biogen partner calls for global Alzheimer's effort Sonova gains two new board members Olympus hires former Ambu CEO Novo Nordisk enters into research collaboration with Lumen Bioscience Large shareholder sells some Orphazyme shares shortly before vital FDA ruling, general partner denies connection EMA to be beefed up for future crises Analyst: Demant's Oticon More generates strong VA figures Former Emisphere investors sue following sale to Novo Nordisk Demant won major market shares at VA in May Sage Therapeutics depression drug disappoints FDA agrees to meeting with Enochian over HIV therapy Novo Holdings plans to enter China Novo Holdings acquires diagnostics company for USD 564m Janssen publicizes more Darzalex data Olympus gets new Regional Managing Director for the Nordics Incyte's atopical dermatitis cream delayed Orphazyme launches investigation into dramatic and mysterious share price roller coaster FDA extends review period for Ascendis Pharma's first drug Bavarian Nordic to supply UK with monkeypox vaccines Equity trader on Orphazyme surprise: "It's a bit like Gamestop all over again" Top news from MedWatch this week Orphazyme CEO on trading explosion: "We have no idea what is going on" Analyst calls Orphazyme's 300 percent value jump "strange and noteworthy" FDA advisors quit after approval of Alzheimer's medicine Newly established firm puts down roots in Denmark Biontech plans to produce mRNA vaccines in Africa WHO: Europe is far from safe from covid-19 Teva and Eli Lilly scrap over migraine drug rights Biogen to start shipping new Alzheimer's drug in two weeks Danish companies: A minimum tax rate has advantages Hearing company enters into first partnership in big venture in India Dementia professor on new Biogen approval: The first small step towards new developments Pfizer gives Danish PM cold shoulder: rejects idea of starting vaccine production in Denmark Bogus drugs and medical equipment abound in Europe Novo Nordisk enters into collaboration with Danish crispr firm Snipr Three global giants consider vaccine production in Denmark FDA heavily criticized by independent institute over Biogen approval Biogen's US Alzheimer's drug may also come to Europe WS Audiology joins Science Based Targets initiative Biogen passes FDA test for Alzheimer's medicine Obesity drug has no competitors on unexploited market, says Novo Nordisk Fate of Biogen’s stock rides on Alzheimer’s drug decision Launch of obesity drug will be Novo Nordisk's fastest ever WHO gives further support to Bavarian Nordic and Johnson & Johnson's Ebola vaccine Demant and GN ramp up investments – with money to spare Novo Nordisk EVP: Semaglutide can double obesity business in few years FDA approves Novo Nordisk's semaglutide as obesity treatment Top news from MedWatch this week G7 ministers: Global tax agreement in sight Audientes CEO: We have the perfect product for the future OTC channel Drugmakers in China take aim at pharma’s lucrative cancer fighters Denmark sends 358,000 surplus vaccines to Kenya EU’s trade response to pandemic stops short of vaccine IP waiver GN CEO: Jabra's strong brand is perfect for Costco Lack of news leaves Lundbeck high and dry GN launches Jabra hearing aid at Costco Analyst: Pentax partnership might lead Ambu to new market Bavarian Nordic hunts for best covid-19 vaccine production setup – may drop current manufacturer Orphazyme's hour of reckoning approaches: "Its existence is threatened if it gets a clear no" Genmab to collaborate with Californian biotech company on three drugs Boehringer Ingelheim and Zealand Pharma's Nash candidate fast tracked by FDA GN and Demant lose VA market shares again Another Genmab drug from Janssen receives breakthrough therapy designation Novo Holdings and Healthcap launch new biotech firm EU deal forces large firms to share tax information FDA approval of semaglutide could help Novo Nordisk access unexploited obesity market New partnership may pave the way for first Novo Nordisk stem cell treatment Pentax forms Chinese partnership for single-use scopes Analysts: Stallergenes' approval may expand the market for allergy tablets Stallergenes gets European approval for dust mite allergy tablet Microbiome venture can start production in Denmark and Switzerland Novo Nordisk enters collaboration with Heartseed on cell-based treatment 316 European residents experienced blood clots following hotly debated vaccine Nordic politicians encouraged to place antibiotic resistance higher on the agenda FDA approves migraine pill as preventative treatment Lundbeck CEO Deborah Dunsire wants to prioritize mental health in the wake of covid-19 Novo Nordisk resubmits higher-dosage Ozempic application to the FDA Ascendis increases expenses shortly before moment of truth Top news from MedWatch this week Carb-X investment gives Snipr Biome validation before going to clinic Travel restrictions bite Bavarian as rabies vaccine sales plunge Novo Nordisk risks insulin shock on Chinese market Novo Nordisk successfully prices Euro medium term notes worth EUR 1.3bn Novo Holdings completes third investment in Asia in one month New sales agreement is another piece of Bavarian Nordic's commercial puzzle Bavarian Nordic partners up with Dynavax on hepatitis B vaccine Darzalex performs well in Janssen's rare disease study Pentax obtains EU approval for single-use scope Bavarian Nordic maintains guidance for 2021 New regulation means stricter requirements for medtech firms EU demands Astrazeneca court order to supply vaccine doses IO Biotech puts down roots in USA and hires new CSO Novo Holdings contributes to USD 540m investment in US health platform Global tax agreement could prompt Novo Nordisk to take tax payments elsewhere Novo Nordisk launches smart insulin pen in Denmark Boston Scientific gets CE marking for single-use bronchoscope Eli Lilly sues HHS in strife over discounted drugs Coloplast recalls urology product Novo Nordisk prepares to launch diabetes tablet in India Genmab partner gets approval for lung cancer drug from Duobody platform EMA gives positive opinion on Genmab's Darzalex in combination treatment Top news from MedWatch this week Coloplast starts new colostomy leakage trial Novo Nordisk to issue Euro medium term notes worth up to EUR 5bn Audientes builds up momentum and prepares for Q3 launch Google app will help detect skin ailments Biotech firm gets Chinese patent on plant substance cocktail for diabetes, obesity and fatty liver prevention Novo Holdings co-leads Swiss funding round Y-mabs enters into partnership with Uruguayan firm to launch cancer drugs in South America Analyst: New study confirms that Eli Lilly's tirzepatide is a good product Lundbeck to push transport sector in greener direction Eli Lilly plans to submit tirzepatide application at the end of the year Biomarin presents new five-year data for hemophilia gene therapy Novo Nordisk looks into repurposing millions of used insulin pens US health authority reprimands large pharmaceutical firms after disagreement on drug discounts Swiss take steps to guarantee supplies of EU medical products Teva CEO on decimated share price: "It's rational enough from a market point of view" Xellia pays steep price for factory delays Novo Holdings takes the lead in investment in new Asian company Swiss hearing aid giant comes out on top after covid-19 crisis ALK expands digital venture with US partnership Leo Pharma starts phase III hand eczema trial Sonova affected by fluctuating currencies in 2020/2021 Novo drug ziltivekimab meets primary endpoint in inflammatory biomarker trial WSA exec quits – internal candidate takes over WSA wants Widex products back in US sales channel Astellas enters into strategic collaboration with Kyoto University Novo Nordisk working on new digital solution for treating patients with insulin Private equity firm Gilde eyes growing potential in Scandinavia Life science executives: We can feel the lack of traveling salespeople Top news from MedWatch this week Six companies show interest in vaccine production in Denmark ALK awaits crucial adrenaline data in 2021 and plans to submit FDA application in less than three years Novo Nordisk's semaglutide shows improved mental and physical wellbeing as obesity treatment Stock market unease causes listing of WSA subsidiary to be postponed Zealand Pharma CEO: "A very busy time for us" Tough competition forces innovation at Ambu Analyst on new Bose hearing aid: "Won't disrupt Danish manufacturers" Electronics firm presents long-awaited hearing solution Ambu fails to live up to revenue forecasts Ambu gets US approval for new product Lundbeck bets on four core products during hard year Analyst believes in continued progress for Ambu GN executive does not envy sister firm's booming success EU readies new lawsuit against Astrazeneca over vaccines Almirall starts the year with solid growth Lundbeck loses top-line terrain but surpasses expectations Swiss hearing aid giant makes EUR 200m acquisition – poised for new US sales channel Covid-19 costs Coloplast USD 33m in extended court cases Lundbeck: Pandemic and currency woes have led to setbacks EU countries are in no hurry to waive vaccine patents Novo Nordisk recalls medicine samples following Texas power outages Olympus targets carbon neutrality by 2030 Top news from MedWatch this week Orphazyme CEO disappointed with failed ALS trial – pins hope on other disease area EU splits on vaccine patent waivers to cast doubt on US plan Genmab CEO on legal fight with Janssen: Standing up straight and fighting for what's morally and ethically right WSA feels a change in the wind: Sees benefits of transparency after 65 years US exercises option for Bavarian Nordic smallpox vaccine Leo Pharma's board chair steps down Genmab is going through a growth spurt and expands on three continents GN flagship product gets off to a bad start with war veterans: "It is an unfortunate cocktail" Coloplast raises EBIT margin guidance WSA raises guidance in first-ever public H1 report Novo Nordisk expands obesity business in spite of obstacles Genmab spent more than DKK 1 billion in Q1 GN Hearing's top line took a dive in Q1 – firm maintains 2021 guidance Difficult conditions in the UK and postponed operations expected to affect Q2 for Coloplast ALK powers ahead on crucial market following new regulations for prescribing medicine Novo Nordisk CEO on disappointing Rybelsus sales: Influenced by lockdown Chinese authorities have approved Novo Nordisk's Ozempic AGC Biologics will produce chronic gout treatment for Horizon Therapeutics Novo Nordisk beats expectations – upgrades outlook ALK's Q1 better than predicted on top and bottom line French reforms and US vaccinations benefit Demant in corona-struck times Analysts to home in on expenses in Genmab's Wednesday fiscal report WSA ready to launch new Signia product platform New top product and Philips range have won market shares for Demant Demant raises financial guidance for 2021 Analyst: Novo Nordisk's year may start with zero growth Analyst predicts that covid-19 will still affect Demant Olympus launches line of single-use scopes Biomarin gets ready for launch in second half-year of 2021 Lundbeck backs Trintellix with new data Pfizer and Biontech request to expand authorization for vaccine for adolescents FDA issues complete response letter to Leo Pharma's tralokinumab Top news from MedWatch this week Danish government will allow gradual vaccine production in Denmark Cancer firm Adcendo raises EUR 51m Bavarian Nordic on vaccine candidate: Preclinical data indicates broad protection Pfizer buys Amplyx Pharmaceuticals from Lundbeckfonden Eli Lilly on tirzepatide data: Surpasses our expectations Boston Scientific had better results in Q1 than predicted Sanofi's Dupixent sales grow 45 percent in Q1 Sanofi's diabetes business shrinks again Y-mabs files for EU approval for pediatric cancer drug Novartis chief sees remote-work hybrid persisting after pandemic Bavarian Nordic may start producing covid-19 vaccines next year Eli Lilly lowers guidance for 2021 Össur advances in all areas after Covid-19-affected year Lundbeck eyes major breakthrough for brain diseases MSD sets carbon neutrality goal EU initiates lawsuit against Astrazeneca for breach of contract Sanofi hits bullseye in phase III trial of treatment for RSV EU expects new portal for clinical trials will be ready in early 2022 GN Hearing kicks off trial with self-fitting hearing aid CHMP recommends eight medicines for approval Top news from MedWatch this week US authorities investigate new death following J&J vaccination EU won't take up option to buy more Astrazeneca vaccines Leo Pharma executive on EU progress: This is a huge milestone for us CHMP recommends Leo Pharma's tralokinumab for approval in atopic dermatitis EU Commission denies report on Astrazeneca lawsuit Analysts lose confidence in Biogen Alzheimer's approval FDA postpones plan for new hearing aid sales channel – again Lundbeck drug shows significantly improved functioning in major depressive disorder EU prepares to file lawsuit against Astrazeneca Novo Nordisk wants obesity tablet to have same effect as injection Novo Nordisk initiates trial with obesity-treating tablet Analyst: Listed subsidiary may pave the way for WSA and take chunk out of massive debt FDA requires more data from Y-mabs Roche reports slightly better sales than predicted in Q1 Verathon gets European approval for single-use product EU politicians plan to focus on Europe's obesity problem Janssen had better Darzalex sales than expected in Q1 Alnylam is at the new frontier of medicines: "It will have the same impact on the industry as antibodies" Janssen receives new approval for Darzalex in Canada WS Audiology plans to list subsidiary Denmark discusses vaccine swap with other countries Sydbank: Expanded ALK approval is good news ALK gains important approval on difficult US market Roche publishes new sclerosis data to keep Novartis at bay Health organizations see danger in Denmark’s decision to stop using Astrazeneca vaccine Top news from MedWatch this week EU likely to decline new vaccine deals with Astrazeneca and J&J Morgan Stanley: 12 new product launches will pave the way for Ambu Danish government makes vaccine production a priority in new life science strategy WS Audiology is the no. 1 applicant for patents within hearing aid industry Gilead scores new FDA approval for drug obtained in billion-dollar purchase WHO: Denmark considers sharing Astrazeneca vaccine with developing countries Here is why the Danish Health Authority stopped using the Astrazaneca vaccine Astrazeneca on vaccine skepticism: "Many forget it's a non-profit project" Genmab CEO on possible settlement in dispute with Janssen: "I have no comment" Investors demand tax transparency from GN Store Nord Danish authorities: Astrazeneca vaccine to be discontinued in Denmark GN Hearing maintains guidance – still predicts 25 percent growth for 2021 Pension fund criticizes Genmab salary packages Boehringer Ingelheim and partner launches stage II trials for NASH and obesity Lundbeck executive remains confident about Alzheimer's drug after new analysis Analyst: Genmab share price may double Orphazyme investor following muscle wasting disappointment: "Now everything has to run smoothly in 2021" Lundbeck carries on Rexulti study after new analysis Novo Ventures company plans to fetch USD 127.5m on the US stock exchange GN lost market shares from veterans in March – again Analyst: Genmab's progress with the FDA sends a positive signal Authorities are closely monitoring blood clot cases following vaccines New Orphazyme CEO has great ambitions: Wants to create new Genmab FDA grants new Genmab drug priority review status Top news from MedWatch this week France wants to mix vaccines – Denmark considers the same Novo puts million-dollar figure towards television commercials Zealand Pharma will soon launch first drug Kesimpta's complicated developmental path has shaped Genmab's approach to partnerships Eli Lilly has to wait a while longer for FDA verdict Danish Health Authority awaits Danish study results before giving verdict on Astrazeneca Lundbeck drug hope moves closer to moment of truth Novo Nordisk tests own mobile app in phase III trial with insulin hope EMA sticks to the recommendation of Astrazeneca's covid-vaccine Hearing aid company fetches million dollar figure in capital raising round Genmab drug becomes more accessible in the US M&A advisors: "We've never seen such investor interest in this service before" Danish Covid-19 therapy shows promise in phase I trial Analyst: Ebola order has positive signal value for Bavarian's investors Hearing aid CEO predicts big rebound after virus year and massive costs shutting down subsidiary Bavarian receives USD 28m order from Janssen FDA investigates infection rates for endoscope use – Olympus and Karl Storz recur in reports One in two Danes would opt out of Astrazeneca vaccine When the world shut down, Roche went all-in and carried on its research programs Astrazeneca fully understands Danish vaccine pause: "It's about maintaining trust in the vaccines" GN intensifies goal: Plans to have at least 25 percent female leaders by 2025 Orifarm got Covid-19 discount on Takeda purchases: "The timing was in our favor" FDA approves new larger production setup for Genmab drug Genmab chief on sclerosis drug launch: Novartis prioritizes us Orphazyme share recovers somewhat after dive CEO after US contract: "For the first time ever, Coloplast has equal access to the market" New Pharmatech CEO expects larger external sales – but this won't weaken relationship with Novo Nordisk Novartis gets approval for Genmab drug against multiple sclerosis in Europe Orphazyme CFO on failed trial: "Highly disappointing and highly surprising" Analyst on US Coloplast contract: Important contract – volumes will probably increase Coloplast gets crucial US deal for ostomy product Trial with Danish coronavirus therapy is prioritized in the UK Democrats want insulin producers investigated Orphazyme fails trial in muscle wasting disease CHMP recommends Novo Nordisk's Saxenda for adolescents Top news from MedWatch this week Novo Nordisk Pharmatech finds new CEO – choice falls on board member EU chief: Astrazeneca must adhere to EU contract to export Bavarian Nordic's CBO quits Virtual Novo Nordisk AGM: Headed for 2025 goal, but pandemic caused fragile public financial situation Danish bank: Lost appeal case paves way for new compensation claims against Lundbeck Lundbeck disappointed over verdict – fine paid in 2013 Novo Holdings has worked large Convatec investment for four years: "Things don't happen overnight" EU Court of Justice turns down Lundbeck appeal – fine still stands Competition authority interferes with Takeda's deal with Danish Orifarm EU vaccine rules may disrupt global supply, including to allies Trust in Astrazeneca vaccine is dropping in Europe Leo Pharma's board now has one person less On 24 occasions employees warned Lundbeck management of foul play Leo Pharma failed on the top line yet succeeded on profit in 2020 Zealand Pharma sends rescue pen on the market in late June Leo Pharma elaborates on 2030 strategy after new capital injection Nordic Capital posts millions of euros in Leo Pharma – gets owner's share at under 25 percent FDA refuses to file Novo Nordisk application Zealand Pharma gets approval for low blood sugar treatment Vaccines hope takes Bavarian Nordic's share price to more than 300 DKK Leo Pharma struggles with lawsuit in the US Covid-19 created many attractive opportunities for Novo Holdings in 2020 Canada orders more smallpox vaccines from Bavarian Nordic Top news from MedWatch this week EU and US to zoom in on pharmaceutical industry mergers Novo increases fatty liver efforts: "We've seen some highly convincing data" Moment of truth for Coloplast's US venture Novo Holdings beats records in 2020 and earns DKK 29bn Vaccines seen protecting against Brazil strain in Oxford study Novo Nordisk and Gilead expand partnership GN chair sees divisional collaborations as advantage New Lundbeck exec to get firm's next research leg started Former Novo employee alleges sexual harassment, discrimination: success meant flirting with boss Bioporto CEO holds Covid-19 test at arm's length: "Could be everything or nothing" Novo Holdings appoints new head of responsible investments Glooko raises just under DKK 190m in financing round with Novo Nordisk as major investor EMA: We're firmly convinced of the benefits of the Astrazeneca vaccine Lundbeck poaches CSO from US biotech firm Novo Nordisk Foundation chair warns against new state-funded vaccine production Galecto ditches high doses in phase II trial Jefferies valuates Bavarian Nordic's Covid-19 project Following recalls and delays, Novo Nordisk kicks off smart insulin pen launch More attacks on Lundbeck's big seller Novo Nordisk has three biopharma blockbusters on the way The Novo Nordisk Foundation discusses Danish vaccine production with government Cochlear gets US clearance for new implant – first to have streaming for both Android and Iphone Novo Nordisk EVP: "When you're the little brother you're still part of the family. This is important to remember" EMA starts rolling review for Eli Lilly's Covid-19 treatment Bavarian Nordic's 2021 will be full of development Top news from MedWatch this week Lundbeck wants Merck EVP as board member Novo Nordisk chairman on lacking diversity: "I haven't done enough" Ascendis powers ahead on capital spending Zealand Pharma CEO before possible approval: We can take major leap WS Audiology balances out male-dominated top management with new coworker Denmark suspends Astrazeneca vaccinations Media: EU is major vaccine exporter in spite of supply problems Bavarian Nordic on new capital raising round: Covid-19 was the decisive factor UK denies EU allegation that vaccine exports have been banned Novo Nordisk tests grand acquisition in phase III trial GN gave off shares to Demant in VA sales channel Fund chief to kickstart fundamental changes in antibiotics market Bavarian Nordic sells discount shares to help fund Covid-19 vaccine Novo Nordisk hires former Director General of DMA Biomarin's previously rejected hemophilia drug gets special status at the FDA Danish government hesitant to rein in EU health response even though industry calls for it Bavarian eases up on categorical statements on Covid-19 vaccine financing Bavarian Nordic still hopes to find financing for Covid-19 vaccine Analyst views clinical results as central to Bavarian Nordic's external financing Novo Nordisk chairman: We must make heaps of strong leaders for ourselves – and for other companies Finance analyst: Eli Lilly deals hard blow to Novo Nordisk with new data Bavarian Nordic presents new preclinical data for Covid-19 vaccine Top news from MedWatch this week EU Commission initiates formal investigation of Teva Novo Nordisk chairman on top wages: "It's a hard balance to strike" Denmark, Israel and Austria to look into the possibility of a joint vaccine production Novo Nordisk chair foresees pressure on pharmaceutical industry Analyst: Lilly doesn't overshadow semaglutide in spite of strong data Eli Lilly surpasses Novo's golden diabetes drug The EMA starts rolling review of Russian vaccine Denmark and Israel have discussed vaccine collab for almost a year Fujifilm starts expanding Danish production facility Global investment firm KKR buys Danish biotech firm share for USD 100m Novo Nordisk lines up for May Alzheimer's trial Ambassador views Teva CEO as important player in potential vaccine alliance Danish PM open towards the idea of establishing vaccine factory Orphazyme CFO: 2021 will be the decisive year Financial analyst raises share price target for Lundbeck due to Rexulti potential Fraudsters offer EU vaccines Genmab and Lundbeck implement sustainability goals in executive incentive programs Orphazyme: Anticipated product approval to secure transformational year Board on new Orphazyme CEO: He has the management style we want Boehringer Ingelheim inks third collab in four years with Danish biotech company Pfizer may present new growth hormone in 2022 Finance analyst: Novo's sales from obesity drugs may grow earlier than anticipated Novo Nordisk Pharmatech to open new sales office in US Orphazyme recruits new CEO Top news from MedWatch this week Novo Nordisk appoints new head of drug discovery Biomarin awaits crucial approvals and flat growth in 2021 Novo Nordisk Pharmatech lands record profits in 2020 Astrazeneca's CEO and colleagues grilled at EU Hearing Coloplast CEO: Digital Denmark has proven worth during Covid-19 Horizon Therapeutics to make blockbuster out of Genmab drug in 2021 Genmab CEO: Three products may turn into five this year Novo Nordisk plans to invest DKK 500m in expanding tablet production facilities Genmab's CEO pulls in DKK 37.3m salary – has shares worth DKK 1.6bn Former FDA top dog joins board of Parkinson's firm EU leaders want to secure vaccine production MC2 Therapeutics aims to lead psoriasis market Novo's dark forecasts have been disproved: "We're stronger in the US than we've been in many years" Genmab CEO: Arbitration might be concluded in 2021 Genmab to take at least one new product to phase III in 2021 Commentator views former Ørsted CEO as potential Novo Nordisk chairman Almirall closes gap in product portfolio through commercialization agreement with MC2 WSA gets Google Country Director for board Former utility boss nominated for new Novo Nordisk board member Novo Holdings buys Canadian life science company Genmab appoints chief medical officer Analyst emphasizes 2021 guidance in Genmab fiscal report Almirall predicts positive 2021 development of psoriasis product Generics companies get green light for Lundbeck drug Flourishing trade activity in life science industry US biotech to submit new psoriasis treatment to the FDA in summer Global antimicrobial fund expands with USD 140m and CEO Cochlear states that its momentum has improved Roche to embrace new technologies early on Ferring divests testosterone drug in new deal Experts: Mandatory release of patents highly unlikely Leo Pharma finds new head of UK and Ireland markets Genmab-developed sclerosis treatment beats competition in small injector pen study Analyst: New Eli Lilly drug doesn't throw Novo Nordisk's Ozempic curveball Eli Lilly's Tirzepatide shows reductions in blood sugar levels and weight Novo Nordisk CEO on his legacy: What I spend most of my time on EMA starts safety-related review of obesity drug Millions of vaccines waiting in warehouses Olympus looks into patient injuries from duodenoscopes Almirall acquires rights to new psoriasis drug in Europe Europe prepares a mutant Covid vaccine plan to fight the crisis Lundbeck's hopes have high costs: "You won't see us reaching that level in the future" Lundbeck hunts for new success drugs in niche diseases Novo Nordisk increases transparency on tax payments Biotech firm raises USD 80m for pharmaceutically treating hearing loss Danish PM is willing to finance vaccine production EMA starts rolling review of Curevac vaccine against Covid-19 Analyst: Eli Lilly considers Alzheimer's submission after phase II Ambu CEO on stream of launches: "Won't be easy, but we're building an ecosystem" Olympus' endoscope sales retreat Retail stakes proved costly for Demant during first coronavirus lockdown ALK invested DKK 1bn in US breakthrough: "It didn't pan out the way we'd hoped" GN Hearing got DKK 103m in state support in 2020 – and laid off a few employees EMA clarifies: No Russian application for vaccine approval Teva plans to take over major chunk of migraine market In spite of Covid-19 lock-downs and sent-home employees, GN have held on to R&D efforts Lundbeck CEO's pay cut in half in 2020 Politicians want their hands on pharmaceutical companies' vaccine patents GN Hearing expects 2021 comeback after tough year Genmab and Seagen submit cancer drug application to US FDA Pharmaceutical company makes commitments to EU antitrust chief Food allergy venture to boost ALK's growth Demant CEO's wages barely changed in Covid-stricken year Lundbeck gets top marks for engaging suppliers in climate efforts ALK winds up with Q4 deficit despite record-breaking revenue Eli Lilly CFO leaves after "exhibiting poor judgment" Analyst: Demant's guidance reflects improved market conditions Demant forecasts better 2021 than pre-corona and hacker attack Demant to boost transparency on differing business developments Demant plans to grow 23-27 percent after two awful years ALK has decent growth forecast in sight Coloplast considers increasing tax payment transparency after criticism Post-pandemic healthcare trends will turn, says SEB's new biotech portfolio lead Demant report looks to future following two horrifying fiscal years Novo Nordisk CEO: Semaglutide could create serious obesity treatment market EU president recognizes responsibility and failures in vaccine purchase Sanofi's diabetes business affected by Q4 falling prices and Covid-19 Sanofi's eczema drug is four-time blockbuster Lundbeck: acquisitions must be well considered EU cancer plan applauded Novo Nordisk kicks off phase III trial program for new insulin hope Ambu expands US contracts with single-use endoscopes Lundbeck on new climate plan: aims for carbon neutrality long before 2050 EU poised to beat cancer Lundbeck plans for carbon neutrality by 2050 Lundbeck beats forecasts considerably in Q4 Novo Nordisk's CFO expects US growth boost this year Coloplast CEO on buying spree: "Something has to happen" Novo Nordisk CEO: Strategy remains constant after Krogsgaard's departure Vaccine disputes may harm pharmaceutical industry's reputation Novo Nordisk expects 5-9 percent sales growth in 2021 Mads Krogsgaard Thomsen resigns from Novo Nordisk EU chief says she was responsible for gaffe over vaccine exports Coloplast surpasses guidance and sets out to launch share buyback program France says Europe vaccine strategy safer than U.K.’s Bavarian Nordic is ready to produce Covid-19 vaccines for other companies GN Hearing introduces new product family in lowest price range WS Audiology loses USD 600m across two years – still withholds net profit guidance Expert committee recommends new Novo Nordisk growth hormone for EU approval WS Audiology books new billion-kroner deficit – lost EUR 243m during virus year Ambu will use pandemic to kick in door to new markets Ambu to raise USD 212m in new capital Ambu surpasses Q1 expectations and hits significant milestone Germany to start registering single-use scopes – Ambu to take advantage Novo Nordisk seeks extended approval for diabetes drug in the US European Medicines Agency: Leaked documents have been manipulated US hospital sales of Novo Nordisk's hemophilia drug dropped in December Leo Pharma goes head to head with Janssen in new psoriasis trial After decades Novo Nordisk approaches historic milestone for obesity market Novo ceases payments to US politicians Coloplast CEO urged to take action: Release the billions! Novo CEO Lars Fruergaard Jørgensen hopes for Eli Lilly's future success WSA puts new man in charge of US brand "After finding out half a million tests were far from enough, we had to work out how to produce five million" Calm Novo Nordisk following Brexit: We had five years to prepare Eli Lilly skyrockets following positive Alzheimer's data Widex family secures power over WS Audiology Pfizer readies to compete against Ascendis and Novo Nordisk: Submits weekly growth hormone to FDA Novo Nordisk selects first drug candidate in Dicerna collaboration Genmab initiates phase III trial with drug against cervical cancer Bavarian Nordic will supply smallpox vaccines to three European countries EU to help vaccine manufacturers expand production Ascendis submits FDA application to start cancer trial Novo Nordisk applies for label extension for diabetes treatment EU to help vaccine manufacturers expand production Sanofi is battle-ready: "We welcome competition, not least from our great colleagues at Leo Pharma" Biotech stocks ready for more Covid-19 results in first quarter Bavarian Nordic defies new failure and maintains efforts in cancer area Hemophilia firm from former Novo employee secures millions from Novo Seeds The Lundbeck Foundation's new strategy: CEO wants to buy more firms like Lundbeck, ALK and Falck Drugmakers agree to halve prices to secure access to China Bavarian Nordic secures second part of smallpox vaccine order from the US Novo Nordisk places stakes on Alzheimer's treatment: hunts for success on the pharmaceutical industry's boulevard of broken dreams Y-mabs closes deals in China and Europe for the firm's two drugs against pediatric cancer Novo Holdings and CEO Kutay on the hunt for billion kroner investment Novo Nordisk files for EU approval for obesity treatment Novo Nordisk to start phase III trial with tablet for Alzheimer's Ambu lands new single-use endoscope contract with US GPO Zealand Pharma disappoints with diabetes drug in phase III Media: Europe aims for vaccine approval on Dec. 23 Orphazyme board on CEO changes: She had an old-fashioned management style Ambu CEO: "We need an innovative speed that's hard to compete with" Novo after crucial data from competitor: Welcomes drug R&D Demant turns up outlook after better-than-expected sales Investcorp buys Danish Sanos Group Sonova receives FDA approval for new technology Coronavirus vaccines are lucrative business Former Novo Nordisk employee plans to revolutionize market for insulin pens Eli Lilly candidate shows weight loss at 11 percent in phase III trial Novo Nordisk withdraws press statement – had misleading marketing Novo Nordisk completes acquisition of Emisphere Technologies Million-dollar investment leads AGC Biologics to start new staff hunt – needs up to 300 new employees Novo Nordisk submits obesity drug for FDA approval New CEO gets rid of a number of Ambu executives Orphazyme opens US headquarters in Chicago and appoints executives Genmab: Janssen applies for approval for lung cancer drug in the US Janssen turns to Danish startup for pill to replace the need to inject drugs Experiences from Covid-19 will create success for Demant's virtual product launch Danish Business Authority's decision causes Lundbeck to downgrade guidance Novo Nordisk loses court case against Sanofi over Danish press statement Incyte expands in Scandinavia and plans to more than double its employees Coloplast CEO: I can calmly declare that the best times are ahead of us Demant launches new flagship product Novo breathes life into Alzheimer's speculations after executive hunt Sonova-owned hearing company plummets on top and bottom lines – survives at the mercy of owner EU plans for better access to low-cost generics and biosimilars in new pharmaceutical strategy Biogen taps Danish biotech firm for collaboration on novel Lupus treatment Genmab ditches drug candidate Galecto fetches former CEO from Aimmune for board Philips has grown stronger from the pandemic: This has been an organizational stress test Hearing aid giants position themselves within US sales channel using new products Novo Nordisk and Biomarin make peace in strife over employees and confidentiality Moderna reveals price of coronavirus vaccine US senators behind over-the-counter hearing aid sales legislation: Get started on sales guidelines! Major medtech supplier teams up with Copenhagen-based startup Novo Nordisk cuts 450 positions in the US Former Widex CEO on chairman prospects: I can deliver in every area GN Hearing lost ground at US VA – and so did Demant Danish-Swedish diabetes company goes on the stock exchange in 2021 Ambu ready for price war on market for single-use devices Irishwoman takes over EMA Executive Director position Bavarian on lacking coronavirus vaccine funding: Sponsors prioritize speed over quality ALK gains millions from webshop – may reach the size of the firm's core market Covid-19 creates uncertainty for Zealand Pharma drug against short bowel syndrome Vaccine researcher lays head on the block: "If Pfizer's Covid-19 vaccine works, so will ours" Startup aims for tailwind after Alzheimer's study involving Novo drug Pandemic kicked off ALK's digitization process Researchers behind Alzheimer's study: GLP-1 drugs show great promise ALK CEO after upgrade: "In spite of Covid-19, ALK is on a roll – I'm really proud" Novo Nordisk acquires collaborative partner for USD 1.8bn Coloplast CEO on expectations: "There are many swing factors" Hungarian factory initiative brings Coloplast one step closer to sustainability goals Novo Nordisk unsure about chance of reaching upper growth target: "This would require significant changes" Eli Lilly prepares obesity efforts with future hope – goes down same path as Novo Nordisk Eli Lilly executive on crucial tirzepatide data: "It is a very exciting time" Coloplast executive: We've had sexism cases, and they've been handled with zero tolerance ALK launches tablet vaccine for tree pollen allergy Coloplast CEO: "It's important for me we don't turn into a company, where it only works if we invented it" FDA plans new sales channel for hearing aids in autumn Novo Nordisk to suppliers: Switch to green transport or lose us as a customer Leo Pharma poised to post DKK billion figure into San Francisco drug: "We're waiting for the trial results" MC2 prepares for US launch by the end of the year Novo Nordisk bets on innovative insulin: "Many doctors said we were crazy" EU advocates general says Lundbeck's DKK 700 million fine is justified Leo Pharma boss on newly purchased drug: "It is a very cleverly designed antibody" Leo gambles on partner’s skin cancer drug even though option agreement is not yet settled Enochian Biosciences has a market cap of $238 million, but researchers doubt the company: "There is no scientific documentation to base their claim on" Sale of hearing aids in the US exceeds 4 million devices for the first time American senators behind over-the-counter hearing aid law demand answers from the FDA: When will the sales guidelines be ready? MIT researcher behind mechanical insulin pills prepared for new Novo partnerships Bavarian will use own money to start RSV trials, but is still seeking a partner Novo Nordisk develops new mechanical insulin pill with star researchers from MIT Danish company prepares to take the psoriasis market by storm – seeks FDA approval Bavarian and other RSV companies navigating uncharted territory Novo Ventures invests millions in Bavarian Nordic rival
1